What is the formulation and route of administration?

This product is a sterile tocilizumab solution administered by intravenous infusion in clinical settings. It is prepared and delivered under the direction of a licensed prescriber with pharmacy and nursing oversight. Clinics use it in infusion suites where staff can manage line setup, monitoring, and documentation. The composition supports controlled administration and standardized workflows across rheumatology and immunology service lines. Always follow institutional policies and the current prescribing information for handling and administration procedures.

Which clinic programs commonly include this therapy?

Specialists may incorporate this agent into programs serving rheumatology and related immunology needs. Labeled indications include rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, and protocols addressing cytokine release–related events. Clinics typically schedule infusion chair time, pharmacy preparation, and observation within a coordinated visit. Utilization should follow prescriber direction, local formulary guidance, and applicable professional standards.

How does it fit into infusion-suite workflows?

It integrates well into established infusion operations. Pharmacy verifies product and prepares the dose per protocol. Nursing completes chair-side checks, line setup, and observation. Documentation captures lot, expiration, and administration details in the EMR. The consistent vial presentation supports predictable setup across visits, and standardized steps help staff maintain safety checks without disrupting other scheduled therapies. Many centers map staffing and chair assignments around recurring infusion intervals to support continuity.

Which excipients are present in the formulation?

The solution contains tocilizumab as the active component with excipients commonly used in parenteral monoclonal antibody formulations, including sucrose, polysorbate 80, arginine hydrochloride, histidine, histidine monohydrochloride monohydrate, and water for injections. This profile supports stability and compatibility with infusion workflows. Pharmacy teams can use these details for allergy screening and inventory documentation within institutional systems. Always consult the current label for the most accurate composition information.

What documentation accompanies shipments for receipt and EMR entry?

Each order includes labeling that displays the product name, lot number, and expiration date. Packing paperwork supports receiving checks, chain-of-custody records, and EMR or charge-capture workflows. This traceability helps align pharmacy inventory control with clinical scheduling, so chair times and therapy plans are not disrupted. If your site requires specific documentation formats, coordinate with our team before shipment so we can align with your internal processes.

Can subcutaneous options be used instead of the IV form?

Both IV and subcutaneous forms of tocilizumab exist, but they are not interchangeable without prescriber approval and the correct NDC selection. Clinics should verify route, formulation, and protocol requirements before ordering. When a program includes subcutaneous tocilizumab, ensure training, storage, and billing workflows match that form. Confirm any transition plan with your medical director and pharmacy leadership to maintain continuity and compliance with labeling and institutional policies.

How do licensed buyers access pricing and supply options?

Create or verify your professional account and sign in to view available presentations and contract tiers. Our team can coordinate forecasted demand with ordering cycles to support infusion scheduling. You can request quotes for formulary or service-line planning and align replenishment with expected chair utilization. If your site operates multiple locations, we can discuss consolidated purchasing to streamline deliveries and documentation across the network.

Rheumatology

Actemra®

Actemra® Solution for Infusion for Clinics

Prescription Medication

Price range: $367.99 through $1,099.00

Description

What Actemra Is and How It Works

Actemra® is tocilizumab supplied as a sterile solution administered by intravenous infusion in supervised clinical settings. It targets the interleukin 6 receptor to help modulate inflammatory activity across relevant autoimmune pathways. Clinics stock this therapy to support rheumatology and immunology infusion services with dependable US distribution and consistent lot access for ongoing patient schedules.

Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.

This preparation is an IL‑6 receptor monoclonal antibody. It is used by specialists in controlled environments, where pharmacy and nursing teams can manage mixing, line setup, monitoring, and documentation. The product’s composition and packaging support standardized infusion workflows and multidisciplinary use.

Professional Applications

Facilities integrate Actemra infusion into physician-directed programs across rheumatology and related services. Typical clinic use includes care pathways for rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, and cytokine release–related protocols per labeled indications. Programs often coordinate infusion chair time, pharmacy preparation, and observation within a single visit to streamline throughput and recordkeeping.

For broader therapy context, teams may review guidance in RA Injection Therapy and explore our Rheumatology category. For clinical background on this agent’s injectable form, see the internal overview Actemra Injection.

Key Features

Class and target: humanized monoclonal antibody to the IL‑6 receptor
Formulation: sterile, preservative-free infusion solution
Administration: hospital or clinic IV administration only
Systemic reach: supports immune modulation across multiple tissues
Pharmacy-friendly: clear labeling, known excipients, predictable preparation
Program fit: aligns with infusion-suite staffing and safety protocols
Documentation: lot and expiration details visible for inventory and EMR entry
Clinical form: Tocilizumab IV formulation for supervised use

Benefits in Practice

Infusion centers value this agent for its consistent presentation and controllable administration. Team workflows can incorporate pharmacy checks, nurse verification, and observation windows without disrupting other services. Standardized processes help reduce chair-time variability and simplify scheduling.

Using an Actemra IV infusion within a unified protocol can streamline safety checks and multidisciplinary coordination. Pharmacy teams can forecast reordering windows based on lot usage, while nursing staff benefit from clear setup steps and compatible accessories. Clinics gain operational clarity across multiple specialties that share the infusion suite.

Composition & Ingredients

This sterile, preservative-free Tocilizumab injection is formulated for IV use under professional supervision. The excipient profile supports product stability and compatibility with infusion workflows.

Active ingredient: Tocilizumab
Excipients: Sucrose; polysorbate 80; arginine hydrochloride; histidine; histidine monohydrochloride monohydrate; water for injections

The formulation and excipients are listed to support pharmacy verification, allergy review, and institutional formulary documentation.

Packaging & Supply

Supply is configured for clinical infusion use and inventory control. External packaging and vial labels provide product name, strength, lot number, and expiration for reconciliation and EMR entry. Presentations may be selected to align with protocol needs and pharmacy compounding practices.

Actemra 200 mg vial (10 mL) solution for infusion
400 mg/20 mL vial solution for infusion
162 mg/0.9 mL presentation per labeling

Each presentation is intended for administration in hospitals or clinics with appropriate monitoring. Vials are suitable for central pharmacy storage and controlled dispensing to the infusion area.

Ordering & Logistics

Account verification is required before purchase. Sign in to view available presentations and your clinic’s volume or contract pricing tiers. Your assigned representative can coordinate order timing for regular infusion days and help align replenishment with forecasted chair utilization.

Orders ship from vetted US partners with clear lot visibility and documentation. Packing documentation includes product identifiers to support receipt checks, chain-of-custody records, and EMR charge capture. For operational planning, notify our team of upcoming protocol launches so we can align inventory lead times with your schedule.

Comparable Products

Clinics evaluating alternatives in the same general therapeutic arena often consider abatacept and infliximab infusion options. Explore Orencia for a selective T‑cell co‑stimulation modulator, and Remicade for a TNF‑alpha inhibitor. For clinical context on these classes, see Orencia Overview and Remicade Overview.

Pricing & Access

Licensed buyers can sign in to view Actemra pricing aligned with your account status. We maintain volume and contract tiers to support infusion-suite planning and multi-site operations. Discuss seasonal utilization trends with our team to align par levels, reduce rush orders, and stabilize the budget around anticipated tocilizumab costs. Quotes can be prepared for formularies and service-line reviews.

Availability & Substitutions

Supply may vary by presentation. Confirm acceptable substitutions with your prescribers and pharmacy leadership before placing orders. If a subcutaneous pathway is approved in your program, the term Actemra injection typically refers to the non‑infusion route; verify formulation and NDC to prevent mismatches. When considering subcutaneous tocilizumab for continuity of care, ensure your protocol, training, and billing workflows reflect the correct form.

Authoritative Sources

For detailed, authoritative information, consult the manufacturer and regulatory resources:

Ready to align inventory with clinical demand? Contact us to schedule supply for your infusion days with temperature-controlled handling when required and tracked US delivery.

Frequently Asked Questions

What is the formulation and route of administration?
This product is a sterile tocilizumab solution administered by intravenous infusion in clinical settings. It is prepared and delivered under the direction of a licensed prescriber with pharmacy and nursing oversight. Clinics use it in infusion suites where staff can manage line setup, monitoring, and documentation. The composition supports controlled administration and standardized workflows across rheumatology and immunology service lines. Always follow institutional policies and the current prescribing information for handling and administration procedures.
Which clinic programs commonly include this therapy?
Specialists may incorporate this agent into programs serving rheumatology and related immunology needs. Labeled indications include rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, and protocols addressing cytokine release–related events. Clinics typically schedule infusion chair time, pharmacy preparation, and observation within a coordinated visit. Utilization should follow prescriber direction, local formulary guidance, and applicable professional standards.
How does it fit into infusion-suite workflows?
It integrates well into established infusion operations. Pharmacy verifies product and prepares the dose per protocol. Nursing completes chair-side checks, line setup, and observation. Documentation captures lot, expiration, and administration details in the EMR. The consistent vial presentation supports predictable setup across visits, and standardized steps help staff maintain safety checks without disrupting other scheduled therapies. Many centers map staffing and chair assignments around recurring infusion intervals to support continuity.
Which excipients are present in the formulation?
The solution contains tocilizumab as the active component with excipients commonly used in parenteral monoclonal antibody formulations, including sucrose, polysorbate 80, arginine hydrochloride, histidine, histidine monohydrochloride monohydrate, and water for injections. This profile supports stability and compatibility with infusion workflows. Pharmacy teams can use these details for allergy screening and inventory documentation within institutional systems. Always consult the current label for the most accurate composition information.
What documentation accompanies shipments for receipt and EMR entry?
Each order includes labeling that displays the product name, lot number, and expiration date. Packing paperwork supports receiving checks, chain-of-custody records, and EMR or charge-capture workflows. This traceability helps align pharmacy inventory control with clinical scheduling, so chair times and therapy plans are not disrupted. If your site requires specific documentation formats, coordinate with our team before shipment so we can align with your internal processes.
Can subcutaneous options be used instead of the IV form?
Both IV and subcutaneous forms of tocilizumab exist, but they are not interchangeable without prescriber approval and the correct NDC selection. Clinics should verify route, formulation, and protocol requirements before ordering. When a program includes subcutaneous tocilizumab, ensure training, storage, and billing workflows match that form. Confirm any transition plan with your medical director and pharmacy leadership to maintain continuity and compliance with labeling and institutional policies.
How do licensed buyers access pricing and supply options?
Create or verify your professional account and sign in to view available presentations and contract tiers. Our team can coordinate forecasted demand with ordering cycles to support infusion scheduling. You can request quotes for formulary or service-line planning and align replenishment with expected chair utilization. If your site operates multiple locations, we can discuss consolidated purchasing to streamline deliveries and documentation across the network.

Specifications

Main Ingredient:
Manufacturer: Roche Products Limited.
Drug Class:
Generic Name: tocilizumab
Package Contents: 1 Vial
Storage Requirements: Room Temperature (2℃~25℃)
Main Usage:

Here to help

Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager

International Shipping

Seamless delivery across the world

Easy Returns

Flexible solutions with our 30 day return policy

Secure Payments

Order confidently with private security network